ThermoGenesis Corp. (NSDQ:KOOLD) is back in the NASDAQ exchange’s good graces.
The Rancho Cordova, Calif.-based stem-cell-storage device maker was in danger of de-listing from the market after its stock price dipped below a minimum $1-per-share requirement.
ThermoGenesis pulled a reverse stock split in August — its second in two months — to stave off the de-listing. The company is temporarily trading under the symbol "KOOL" with a "D" added to signify the split.
"We finished fiscal 2010 in strong fashion and are off to a solid start in fiscal 2011 as we execute on our strategies to drive shareholder value," CEO J. Melville Engle said in prepared remarks.
At DeviceTalks Boston, Tyler Shultz will give attendees an inside look at Theranos and how he was able to sound the alarm after he realized the company was falling apart. Shultz will take attendees behind the story that everyone is talking about: the rise and fall of Elizabeth Holmes and her diagnostic company, Theranos.
Join Shultz and 1,000+ medical device professionals at the 8th annual DeviceTalks Boston.